We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva, Barr Join for At-Risk Launch of Generic Allegra
Teva, Barr Join for At-Risk Launch of Generic Allegra
September 20, 2005
Rivals Barr Pharmaceuticals and Teva Pharmaceutical have partnered to market a generic version of sanofi-aventis’ blockbuster allergy drug Allegra, the companies said Sept. 6. Barr received final FDA approval to market its version of the drug last week.